Corey Dean Klassen

Corey Dean Klassen discloses dealings in Marapharm Ventures Inc. to SEDI. Between 5 August 2016 and 28 June 2018, the trades on record add up to 21 filings.

The open-market side counts 2 purchases for €15k alongside 16 sales for €111k. Sales outweigh purchases by €95k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 3 option exercises. 2018 to date brings 1 purchase and 6 sales.

Most recently, on 4 July 2018, the filings show an open-market purchase worth €1,566 in Marapharm Ventures Inc. Between a trade and the moment it shows up on SEDI, the median delay is 7 days. The shorter that gap, the sooner other investors can see what insiders have done. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.